Related Experiment Video
Updated: Aug 12, 2026

07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3
Ozlem Goker-Alpan1, Raphael Schiffmann, Joseph K Park
1Section on Molecular Neurogenetics, NIMH/NIH, 49 Convent Drive, MSC 4405, Bethesda, MD 20892-4405, USA.
The Journal of Pediatrics
|September 13, 2003
Summary
Neuronopathic Gaucher disease presents a spectrum of phenotypes. This study identified an intermediate form in nine children with delayed onset but rapid neurological decline, including seizures and oculomotor issues.
Area of Science:
- Neurology
- Genetics
- Rare Diseases
Background:
- Neuronopathic Gaucher disease (GBA1-PD) exhibits diverse clinical presentations.
- Traditional classification into types I and II often fails to capture the full phenotypic spectrum.
- A continuum of phenotypes complicates diagnosis and management.
Purpose of the Study:
- To characterize an intermediate phenotype of neuronopathic Gaucher disease.
- To describe the clinical and genotypic features of affected children.
- To improve understanding of Gaucher disease heterogeneity.
Main Methods:
- Retrospective case series analysis.
- Clinical data collection including neurological assessments and seizure history.
- Genotypic analysis to identify mutations in the GBA1 gene.
Main Results:
- Nine children presented with a delayed onset but rapidly progressive neurological phenotype.
- Key features included refractory seizures and oculomotor abnormalities.
- Genotypic heterogeneity was observed among the patients, indicating diverse underlying mutations.
Conclusions:
- An intermediate phenotype of neuronopathic Gaucher disease exists, characterized by specific neurological manifestations.
- This phenotype presents challenges in traditional disease categorization.
- Understanding genotypic heterogeneity is crucial for comprehensive Gaucher disease management.
More Related Videos
Related Concept Videos
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

